Related references
Note: Only part of the references are listed.Development and psychometric properties of the Swedish ALPS-Neo pain and stress assessment scale for newborn infants
Pia Lundqvist et al.
ACTA PAEDIATRICA (2014)
Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes
Maria Andersson et al.
DRUG TESTING AND ANALYSIS (2014)
Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotype
Maja Matic et al.
PHARMACOGENOMICS (2014)
Association of OPRM1 and COMT Single-Nucleotide Polymorphisms With Hospital Length of Stay and Treatment of Neonatal Abstinence Syndrome
Elisha M. Wachman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Does neonatal morphine use affect neuropsychological outcomes at 8 to 9 years of age?
Joke de Graaf et al.
PAIN (2013)
Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain
Torill Fladvad et al.
PHARMACOGENETICS AND GENOMICS (2013)
Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg
Aline Hajj et al.
PHARMACOGENOMICS (2013)
Pharmacological treatment of neonatal pain: In search of a new equipoise
Karel Allegaert et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2013)
Is ethnicity associated with morphine's side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy
Nathalia Jimenez et al.
PEDIATRIC ANESTHESIA (2012)
Pharmacogenomics of opioids and perioperative pain management
Senthilkumar Sadhasivam et al.
PHARMACOGENOMICS (2012)
A randomised controlled trial on the efficacy and side-effect profile (nausea/vomiting/sedation) of morphine-6-glucuronide versus morphine for post-operative pain relief after major abdominal surgery
Alexander R. Binning et al.
EUROPEAN JOURNAL OF PAIN (2011)
Determination of remifentanil in human plasma by liquid chromatography-tandem mass spectrometry utilizing micro extraction in packed syringe (MEPS) as sample preparation
Rana Said et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Rapid Sequence Induction is Superior to Morphine for Intubation of Preterm Infants: A Randomized Controlled Trial
Elisabeth Norman et al.
JOURNAL OF PEDIATRICS (2011)
Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: Five-year follow-up of a randomized controlled trial
Joke de Graaf et al.
PAIN (2011)
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer
Ken-ichi Fujita et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
In Vivo Glucuronidation Activity of Drugs in Neonates: Extensive Interindividual Variability Despite Their Young Age
Karel Allegaert et al.
THERAPEUTIC DRUG MONITORING (2009)
UGT2B7 promoter variant-840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease
Deepika S. Darbari et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Postmenstrual age and CYP2D6 polymorphisms determine tramadol O-demethylation in critically I11 neonates and infants
Karel Allegaert et al.
PEDIATRIC RESEARCH (2008)
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties
Shuji Ohno et al.
DRUG METABOLISM AND DISPOSITION (2008)
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on acyl-MPAG production in vitro and in adult renal transplant patients
Nassim Djebli et al.
PHARMACOGENETICS AND GENOMICS (2007)
Environmental and genetic factors associated with morphine response in the postoperative period
L Coulbault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity
Y Duguay et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Neonatal procedural pain and preterm infant cortisol response to novelty at 8 months
RE Grunau et al.
PEDIATRICS (2004)
A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine
MB Sawyer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients
M Holthe et al.
PHARMACOGENOMICS JOURNAL (2003)
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy
M Holthe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers
BP Murthy et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Development and initial validation of the EDIN scale, a new tool for assessing prolonged pain in preterm infants
T Debillon et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2001)
Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance
CR Bhasker et al.
PHARMACOGENETICS (2000)
Share Paper
